Sorry, no content matched your criteria.
Featured Story
Chelsea Therapeutics (Nasdaq: CHTP) Stock Climbs 31% Today on $685 Million Deal
Chelsea Therapeutics (Nasdaq: CHTP) stock soared 31.30% to $6.59 today (Thursday) after agreeing to be acquired by Danish pharmaceutical company H. Lundbeck in a deal valued at $658 million.
Terms of the deal are related to the performance of Chelsea's key drug Northera.
Here are the details – and a look at how CHTP became one of the hottest stocks of 2014.
Chelsea Therapeutics (Nasdaq: CHTP) stock soared 31.30% to $6.59 today (Thursday) after agreeing to be acquired by Danish pharmaceutical company H. Lundbeck in a deal valued at $658 million.
Terms of the deal are related to the performance of Chelsea's key drug Northera.
Here are the details – and a look at how CHTP became one of the hottest stocks of 2014.